Gut Barrier & Immune Research
KPV 10mg
KPV 10mg
Three amino acids focused on barrier and inflammatory pathways.
An alpha-MSH-derived tripeptide explored in inflammatory signalling, epithelial-barrier integrity and mucosal-repair models.
- Documentation
- Check batch record
- Availability
- In stock
For qualified laboratory research only · Not for human or veterinary use
Why researchers choose it
KPV is the Lys-Pro-Val fragment of alpha-MSH and has been studied in cellular and animal models involving NF-κB activity, epithelial transport and inflammatory signalling.
Research focus
- Inflammatory-pathway research
- Epithelial and mucosal-barrier models
- PepT1-mediated transport studies
Evidence snapshot
The evidence is preclinical. It does not establish treatment of inflammatory bowel disease, gut healing, immune regulation or another human outcome.
Best suited to
For controlled barrier and inflammatory-signalling research with model and delivery system documented.
Research focus describes published study domains, not a guaranteed outcome. No human or veterinary dosing, reconstitution or administration instructions are supplied.
Related research compounds
Gut Barrier & Immune600mg
The body’s endogenous tripeptide at the centre of cellular redox control, antioxidant defence and oxidative-stress research.